Margaret E Ackerman
Overview
Explore the profile of Margaret E Ackerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
5041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hederman A, Remmel C, Sharma S, Natarajan H, Weiner J, Wrapp D, et al.
J Clin Invest
. 2024 Aug;
134(20).
PMID: 39207860
BACKGROUNDMost humans have been infected with cytomegalovirus (CMV) by midlife without clinical signs of disease. However, in settings in which the immune system is undeveloped or compromised, the virus is...
12.
McCoy K, Ackerman M, Grigoryan G
Protein Sci
. 2024 Aug;
33(9):e5127.
PMID: 39167052
The ability to accurately predict antibody-antigen complex structures from their sequences could greatly advance our understanding of the immune system and would aid in the development of novel antibody therapeutics....
13.
Hill-Batorski L, Weiner J, Ackerman M, Hatta Y, Hoft D, Herber R, et al.
J Infect Dis
. 2024 Jul;
231(1):214-218.
PMID: 39012796
No abstract available.
14.
15.
Connor R, Sakharkar M, Rappazzo C, Kaku C, Curtis N, Shin S, et al.
Pathog Immun
. 2024 Jun;
9(2):1-24.
PMID: 38933606
Background: Fcγ-receptor (FcγR)-independent enhancement of SARS-CoV-2 infection mediated by N-terminal domain (NTD)-binding monoclonal antibodies (mAbs) has been observed , but the functional significance of these antibodies is less clear. Methods:...
16.
Walsh S, Gay C, Karuna S, Hyrien O, Skalland T, Mayer K, et al.
PLoS Med
. 2024 Jun;
21(6):e1004329.
PMID: 38913710
Background: Broadly neutralizing antibodies (bnAbs) are a promising approach for HIV-1 prevention. In the Antibody Mediated Prevention (AMP) trials, a CD4-binding site targeting bnAb, VRC01, administered intravenously (IV), demonstrated 75%...
17.
Xu S, Ackerman M
BMC Bioinformatics
. 2024 Jun;
25(1):218.
PMID: 38898392
Background: Compared to traditional supervised machine learning approaches employing fully labeled samples, positive-unlabeled (PU) learning techniques aim to classify "unlabeled" samples based on a smaller proportion of known positive examples....
18.
Taton M, Willems F, Widomski C, Georges D, Martin C, Jiang Y, et al.
EBioMedicine
. 2024 Jun;
104:105179.
PMID: 38848615
Background: Maternal pertussis vaccination with Tdap vaccine is recommended to protect newborns from severe postnatal infection. HIV-exposed uninfected (HEU) infants have a higher incidence of pertussis infection and may particularly...
19.
Godin A, Connor R, Degefu H, Rosato P, Wieland-Alter W, Axelrod K, et al.
J Infect Dis
. 2024 May;
230(5):e1023-e1030.
PMID: 38809190
Background: Although polioviruses (PVs) replicate in lymphoid tissue of both the pharynx and ileum, research on polio vaccine-induced mucosal immunity has predominantly focused on intestinal neutralizing and binding antibody levels...
20.
Abdullah L, Emiliani F, Vaidya C, Stuart H, Kolling F, Ackerman M, et al.
bioRxiv
. 2024 Apr;
PMID: 38585810
Generating balanced populations of CD8 effector and memory T cells is necessary for immediate and durable immunity to infections and cancer. Yet, a definitive understanding of CD8 differentiation remains unclear....